Methotrexate (MTX) is by far the most popular oral agent used by dermatologists today for psoriasis and has been so for the last 40 years. Its epitaph was nearly written after the more potent biologic immunomodulators such as Enbrel and Humira were predicted to render MTX obsolete. Now it appears that … Continue reading →
Psoriasis is a heavy burden for both the physical and economic health of the nation, affecting about 7.5 million Americans. The annual cost for treating psoriasis in the U.S. in 2008 was $11.25 billion. The average cost per patient, estimated at $5500 per year, is much higher for more severe … Continue reading →
The answer to the question depends on the extent of training in dermatology and the individual physician’s comfort level in dealing with skin diseases. Currently, the definition of “primary care providers” includes family practitioners, internists, pediatricians, and gynecologists, but may be expanded to include nurse practitioners. The education of U.S. medical … Continue reading →
Dr. Camisa is board certified in dermatology and dermatological immunology, practicing medicine for over 30 years. He is Director of the Phototherapy Department at Riverchase Dermatology and an Affiliate Associate Professor of Dermatology at the University of South Florida in Tampa. He specializes in psoriasis, lichen planus, bullous diseases, connective tissue diseases, cutaneous T-cell lymphoma, and diseases of the mouth and lips. Dr. Camisa is a leading expert in psoriasis, bullous disease, and other complex skin conditions, and patients throughout the country seek his experience. More about Dr. Camisa...